Parathyroid hormone-related protein (PTHrP) and malignancy

Vitam Horm. 2022:120:133-177. doi: 10.1016/bs.vh.2022.03.002. Epub 2022 Jul 25.

Abstract

PTHrP (parathyroid hormone related protein) is an important mediator of malignancy-related tumor progression and hypercalcemia that shares considerable homology and functionality with parathyroid hormone. In this chapter, we review what has been elucidated to date regarding PTHrP's role in malignancies. Starting with a review of calcium metabolism and regulation, we then summarize the discovery and structure of PTHrP and development of sensitive immunoassays for specific measurement. Subsequently, we explore its role in tumor progression, with emphasis on the primary tumor as well as skeletal and non-osseus metastases. We then consider the clinical implications of PTHrP in cancer before concluding with a discussion of both established and potential treatments for malignancy associated hypercalcemia and bone metastases.

Keywords: Breast cancer; Cachexia; Genetically engineered animal models (GEAM); Malignancy associated hypercalcemia (MAH); PTHrP immunoassays; Pancreatic cancer; Parathyroid hormone related protein (PTHrP); Skeletal metastases; Therapeutic monoclonal antibodies; Tumor progression.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Neoplasms* / secondary
  • Calcium
  • Humans
  • Hypercalcemia*
  • Paraneoplastic Syndromes*
  • Parathyroid Hormone
  • Parathyroid Hormone-Related Protein / metabolism

Substances

  • Parathyroid Hormone
  • Parathyroid Hormone-Related Protein
  • Calcium

Grants and funding